#USA #financial results #Milpitas #Zepp Health #Amazfit

Zepp Health's Impressive Financial Performance in 2025

Zepp Health Corporation, known for its innovative smart wearables and health technology solutions, recently unveiled its unaudited financial results for the fourth quarter and the entire year of 2025. The company has demonstrated exceptional growth and adaptability in a competitive market, showcasing its commitment to being a leader in the health tech industry.

In the fourth quarter of 2025, Zepp reported revenues of $85.2 million, which represents a remarkable 43% year-over-year increase. This achievement not only met the upper bound of the company's guidance but also reflects significant sales growth across its diverse product lines, particularly its Amazfit-branded smartwatches and fitness trackers. The company’s gross margin soared to a record-breaking 40.4%, representing an increase of 3.6% compared to the same time last year. This enhancement in margin was largely credited to a favorable product mix and the strategic pricing practices that the company implemented during key sales events like Black Friday and Christmas.

Despite facing economic challenges such as fluctuations in foreign currency and increases in memory chip costs, Zepp's effective inventory management helped mitigate these issues. The company's inventory decreased to $72.8 million, down from $87.7 million earlier in the year, reflecting ongoing improvements in stock management as they prepared for new product launches.

Looking at the broader picture, Zepp Health’s total revenue for 2025 reached $258.9 million, marking a 41.8% increase from the previous year. This growth was underpinned by a significant expansion in sales of Amazfit products, which accounted for 100% of the revenue. Additionally, Zepp’s adjusted net loss for 2025 was trimmed to $31.5 million, down from $56.7 million in 2024, reflecting the effectiveness of their ongoing transformation strategy.

The company is not just focused on financial growth; it is also enhancing its product portfolio. The introduction of new smartwatches, such as the Amazfit Active Max and Amazfit T-Rex Ultra 2, aimed at both daily fitness enthusiasts and outdoor adventurers, showcases Zepp's commitment to catering to a diverse user base. The new Amazfit Active 3 Premium, aimed at entry-level runners, includes structured guidance and advanced running metrics to help users achieve their fitness goals.

Zepp Health has also expanded its Amazfit Athletes team, welcoming notable athletes to its roster, thus boosting brand recognition and promoting its products within competitive sports communities. The return of established athlete Hunter McIntyre, alongside the addition of marathon runner Amanal Petros and Olympic athlete Josh Kerr, highlights Zepp's dedication to integrating with the athletic world.

As Zepp looks ahead, it expects to maintain the momentum set in 2025 into the first quarter of 2026, forecasting revenues between $50 million and $55 million, which would represent approximately 30% to 43% growth year-over-year. This optimism is bolstered by strong operational performance and a clear strategy for future product expansions and brand positioning.

In conclusion, 2025 has been a pivotal year for Zepp Health, demonstrating not only significant financial gains but also a strategic shift towards premium offerings and deeper market engagement. With its eyes set firmly on the future, Zepp Health Corporation continues to strengthen its market position in the wearables and health technology sectors, promising exciting developments ahead for both the company and its customers.